Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Clinical trial update on the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Povorcitinib (povorcitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: RECRUITING